Pharmacoethnicity in paclitaxel-induced sensory peripheral neuropathy

Clinical Cancer Research

Volumn 21, Issue 19, 2015, Pages 4337-4346

  Komatsu, Masaaki ^a   Wheeler, Heather E ^a   Chung, Suyoun ^a,b   Low, Siew Kee ^c,d   Wing, Claudia ^a   Delaney, Shannon M ^a   Gorsic, Lidija K ^a   Takahashi, Atsushi ^c   Kubo, Michiaki ^c   Kroetz, Deanna L ^e   Zhang, Wei ^f   Nakamura, Yusuke ^a,d   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; DEAD BOX PROTEIN; PACLITAXEL; AIPL1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; DDX54 PROTEIN, HUMAN; EYE PROTEIN; TUMOR PROTEIN;

AFRICAN; AIPL1 GENE; ARTICLE; ASIAN; BCR GENE; CONTROLLED STUDY; CYTOTOXICITY; DDX54 GENE; EUROPEAN; EXPRESSION QUANTITATIVE TRAIT LOCI; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MALE; NERVE CELL; PACLITAXEL INDUCED CYTOTOXICITY; PACLITAXEL INDUCED SENSORY PERIPHERAL NEUROPATHY; PERIPHERAL NEUROPATHY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PERIPHERAL NERVOUS SYSTEM DISEASES; PHARMACOGENETICS; PROCEDURES; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DEAD-BOX RNA HELICASES; EYE PROTEINS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEOPLASM PROTEINS; NEURONS; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-BCR;

EID: 84945539383     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-15-0133     Document Type: Article

References (56)

1. Crown J, O'Leary M. The taxanes: an update. Lancet 2000;355:1176-8.
2. Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E, et al. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 2005;23:5542-51.
3. Winer EP, Berry DA, Woolf S, Duggan D, Kornblith A, Harris LN, et al. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol 2004;22:2061-8.
4. Cavaletti G, Alberti P, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics. Lancet Oncol 2011;12: 1151-61.
5. Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, et al. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 2011;29:1472-8.
6. Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther 2011;90:377-87.
7. Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapyinduced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2014;32:1941-67.
8. Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013;309:1359-67.
9. Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res 2012; 18:5099-109.
10. Leandro-Garcia LJ, Inglada-Perez L, Pita G, Hjerpe E, Leskela S, Jara C, et al. Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy. J Med Genet 2013;50:599-605.
11. Wheeler HE, Maitland ML, Dolan ME, Cox NJ, Ratain MJ. Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet 2013;14:23-34.
12. Low SK, Takahashi A, Mushiroda T, Kubo M. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics. Clin Cancer Res 2014;20:2541-52.
13. Cox NJ, Gamazon ER, Wheeler HE, Dolan ME. Clinical translation of cell-based pharmacogenomic discovery. Clin Pharmacol Ther 2012;92: 425-7.
14. Wheeler HE, Gamazon ER, Wing C, Njiaju UO, Njoku C, Baldwin RM, et al. Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res 2013;19:491-9.
15. Wheeler HE, Gonzalez-Neira A, Pita G, de la Torre-Montero JC, Alonso R, Lopez-Fernandez LA, et al. Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses. Pharmacogenet Genomics 2014;24:231-7.
16. Schneider BP, Li L, Miller K, Flockhart DA, Radovich M, Hancock BA, et al. Genetic associations with taxane-induced neuropathy by a genome-wide association study in E5103. J Clin Oncol 2011;29:Suppl:1000.
17. O'Donnell PH, Dolan ME. Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy. Clin Cancer Res 2009;15: 4806-14.
18. He X, Fuller CK, Song Y, Meng Q, Zhang B, Yang X, et al. Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. Am J Hum Genet 2013;92:667-80.
19. Njiaju UO, Gamazon ER, Gorsic LK, Delaney SM, Wheeler HE, Im HK, et al. Whole-genome studies identify solute carrier transporters in cellular susceptibility to paclitaxel. Pharmacogenet Genomics 2012;22: 498-507.
20. Genomes ProjectCAbecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012;491:56-65.
21. Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 2007;81:1084-97.
22. Zhou X, Stephens M. Genome-wide efficient mixed-model analysis for association studies. Nat Genet 2012;44:821-4.
23. Low SK, Chung S, Takahashi A, Zembutsu H, Mushiroda T, Kubo M, et al. Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. Cancer Sci 2013;104:1074-82.
24. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, et al. SCAN: SNP and copy number annotation. Bioinformatics 2010;26: 259-62.
25. Gamazon ER, Huang RS, Cox NJ, Dolan ME. Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc Natl Acad Sci U S A 2010;107:9287-92.
26. Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N, Kubo M, et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 2008;83:445-56.
27. Duan S, Huang RS, Zhang W, Bleibel WK, Roe CA, Clark TA, et al. Genetic architecture of transcript-level variation in humans. Am J Hum Genet 2008;82:1101-13.
28. Wheeler HE, Wing C, Delaney SM, Komatsu M, Dolan ME. Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells. PLoS ONE 2015;10:e0118020.
29. Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, et al. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA 2015; 313:815-23.
30. Goecks J, Nekrutenko A, Taylor J, Galaxy T. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010;11:R86.
31. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013;14:R36.
32. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012;9:357-9.
33. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010;28:511-5.
34. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, et al. Population genomics of human gene expression. Nat Genet 2007;39: 1217-24.
35. Oh D, Han S, Seo J, Lee JR, Choi J, Groffen J, et al. Regulation of synaptic Rac1 activity, long-term potentiation maintenance, and learning and memory by BCR and ABR Rac GTPase-activating proteins. J Neurosci 2010;30:14134-44.
36. Kaartinen V, Nagy A, Gonzalez-Gomez I, Groffen J, Heisterkamp N. Vestibular dysgenesis in mice lacking Abr and Bcr Cdc42/RacGAPs. Dev Dyn 2002;223:517-25.
37. Park AR, Oh D, Lim SH, Choi J, Moon J, Yu DY, et al. Regulation of dendritic arborization by BCR Rac1 GTPase-activating protein, a substrate of PTPRT. J Cell Sci 2012;125:4518-31.
38. Zhan R, Yamamoto M, Ueki T, Yoshioka N, Tanaka K, Morisaki H, et al. A DEAD-box RNA helicase Ddx54 protein in oligodendrocytes is indispensable for myelination in the central nervous system. J Neurosci Res 2013;91:335-48.
39. International HapMap C. The International HapMap Project. Nature 2003;426:789-96.
40. Pastinen T, Ge B, Gurd S, Gaudin T, Dore C, Lemire M, et al. Mapping common regulatory variants to human haplotypes. Hum Mol Genet 2005;14:3963-71.
41. Zhang W, Duan S, Kistner EO, Bleibel WK, Huang RS, Clark TA, et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet 2008;82:631-40.
42. Huang RS, Gamazon ER, Ziliak D, Wen Y, Im HK, Zhang W, et al. Population differences in microRNA expression and biological implications. RNA Biol 2011;8:692-701.
43. Moen EL, Zhang X, Mu W, Delaney SM, Wing C, McQuade J, et al. Genomewide variation of cytosine modifications between European and African populations and the implications for complex traits. Genetics 2013;194: 987-96.
44. Hause RJ, Stark AL, Antao NN, Gorsic LK, Chung SH, Brown CD, et al. Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels. Am J Hum Genet 2014;95:194-208.
45. Huang RS, Kistner EO, Bleibel WK, Shukla SJ, Dolan ME. Effect of population and gender on chemotherapeutic agent-induced cytotoxicity. Mol Cancer Ther 2007;6:31-6.
46. Hartford CM, Duan S, Delaney SM, Mi S, Kistner EO, Lamba JK, et al. Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. Blood 2009;113:2145-53.
47. Stark AL, Hause RJ Jr, Gorsic LK, Antao NN, Wong SS, Chung SH, et al. Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy. PLoS Genet 2014;10:e1004192.
48. Rivera E, Cianfrocca M. Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer. Cancer Chemother Pharmacol 2015;75:659-70.
49. Pulido R, Stoker AW, Hendriks WJ. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease. Hum Mol Genet 2013;22:R66-76.
50. Niemi NM, Lanning NJ, Westrate LM, MacKeigan JP. Downregulation of the mitochondrial phosphatase PTPMT1is sufficient to promote cancer cell death. PLoS ONE 2013;8:e53803.
51. Tan MH, Mackay DS, Cowing J, Tran HV, Smith AJ, Wright GA, et al. Leber congenital amaurosis associated with AIPL1: challenges in ascribing disease causation, clinical findings, and implications for gene therapy. PLoS ONE 2012;7:e32330.
52. Duno M, Wibrand F, Baggesen K, Rosenberg T, Kjaer N, Frederiksen AL. A novel mitochondrial mutation m.8989G>C associated with neuropathy, ataxia, retinitis pigmentosa - the NARP syndrome. Gene 2013;515:372-5.
53. Kirschman LT, Kolandaivelu S, Frederick JM, Dang L, Goldberg AF, Baehr W, et al. The Leber congenital amaurosis protein, AIPL1, is needed for the viability and functioning of cone photoreceptor cells. Hum Mol Genet 2010;19:1076-87.
54. LaPointe NE, Morfini G, Brady ST, Feinstein SC, Wilson L, Jordan MA. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. Neurotoxicology 2013;37: 231-9.
55. Laurent CE, Smithgall TE. The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Racand Cdc42-dependent manner. Exp Cell Res 2004;299:188-98.
56. Huang PT, Chen CH, Hsu IU, Salim SA, Kao SH, Cheng CW, et al. Huntingtin-associated protein 1 interacts with breakpoint cluster region protein to regulate neuronal differentiation. PLoS ONE 2015; 10:e0116372.